These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 2103379

  • 1. In vivo model development of cisplatin-resistant and -sensitive A2780 human ovarian carcinomas.
    Rose WC, Basler GA.
    In Vivo; 1990; 4(6):391-6. PubMed ID: 2103379
    [Abstract] [Full Text] [Related]

  • 2. Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues.
    Behrens BC, Hamilton TC, Masuda H, Grotzinger KR, Whang-Peng J, Louie KG, Knutsen T, McKoy WM, Young RC, Ozols RF.
    Cancer Res; 1987 Jan 15; 47(2):414-8. PubMed ID: 3539322
    [Abstract] [Full Text] [Related]

  • 3. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI, Boxall FE, Goddard PM, Valenti M, Jones M, Murrer BA, Abrams M, Kelland LR.
    Clin Cancer Res; 1997 Nov 15; 3(11):2063-74. PubMed ID: 9815598
    [Abstract] [Full Text] [Related]

  • 4. Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug.
    Kelland LR, Abel G, McKeage MJ, Jones M, Goddard PM, Valenti M, Murrer BA, Harrap KR.
    Cancer Res; 1993 Jun 01; 53(11):2581-6. PubMed ID: 8388318
    [Abstract] [Full Text] [Related]

  • 5. Comparative activity and distribution studies of five platinum analogues in nude mice bearing human ovarian carcinoma xenografts.
    Boven E, van der Vijgh WJ, Nauta MM, Schlüper HM, Pinedo HM.
    Cancer Res; 1985 Jan 01; 45(1):86-90. PubMed ID: 4038381
    [Abstract] [Full Text] [Related]

  • 6. [Antitumor activity of platinum analogs against human ovarian tumors heterotransplanted into nude mice].
    Sawada M, Ozaki M, Hongo J, Hirota Y, Inagaki M, Taniguchi H, Tateishi R, Mori Y.
    Gan To Kagaku Ryoho; 1987 Mar 01; 14(3 Pt 1):693-8. PubMed ID: 3548596
    [Abstract] [Full Text] [Related]

  • 7. Novel phosphonium salts display in vitro and in vivo cytotoxic activity against human ovarian cancer cell lines.
    Manetta A, Gamboa G, Nasseri A, Podnos YD, Emma D, Dorion G, Rawlings L, Carpenter PM, Bustamante A, Patel J, Rideout D.
    Gynecol Oncol; 1996 Feb 01; 60(2):203-12. PubMed ID: 8631539
    [Abstract] [Full Text] [Related]

  • 8. Development of resistance to cisplatin is associated with decreased expression of the gp185c-erbB-2 protein and alterations in growth properties and responses to therapy in an ovarian tumor cell line.
    Langton-Webster BC, Xuan JA, Brink JR, Salomon DS.
    Cell Growth Differ; 1994 Dec 01; 5(12):1367-72. PubMed ID: 7696185
    [Abstract] [Full Text] [Related]

  • 9. Sensitization of cis-platinum by a recombinant adenovirus vector expressing wild-type p53 gene in human ovarian carcinomas.
    Song K, Li Z, Seth P, Cowan KH, Sinha BK.
    Oncol Res; 1997 Dec 01; 9(11-12):603-9. PubMed ID: 9563008
    [Abstract] [Full Text] [Related]

  • 10. Role of carrier ligand in platinum resistance of human carcinoma cell lines.
    Schmidt W, Chaney SG.
    Cancer Res; 1993 Feb 15; 53(4):799-805. PubMed ID: 8428361
    [Abstract] [Full Text] [Related]

  • 11. Antitumor activity of 13,14-dihydro-15-deoxy-delta7-prostaglandin-A1-methyl ester integrated into lipid microspheres against human ovarian carcinoma cells resistant to cisplatin in vivo.
    Sasaki H, Niimi S, Akiyama M, Tanaka T, Hazato A, Kurozumi S, Fukushima S, Fukushima M.
    Cancer Res; 1999 Aug 15; 59(16):3919-22. PubMed ID: 10463583
    [Abstract] [Full Text] [Related]

  • 12. In vivo studies of adenovirus-mediated p53 gene therapy for cis-platinum-resistant human ovarian tumor xenografts.
    Song K, Cowan KH, Sinha BK.
    Oncol Res; 1999 Aug 15; 11(3):153-9. PubMed ID: 10527075
    [Abstract] [Full Text] [Related]

  • 13. [Comparative studies of the antitumor activities of CDDP and the analogs--using gynecological carcinomas transplanted into nude mice].
    Suzumori K, Yasui Y, Suzumori K, Yagami Y.
    Gan To Kagaku Ryoho; 1989 Mar 15; 16(3 Pt 1):387-91. PubMed ID: 2649007
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and activity of a trinuclear platinum complex: [{trans-PtCl(NH3)2}2mu-{trans-Pt(3-hydroxypyridine)2(H2N(CH2)6NH2)2}]Cl4 in ovarian cancer cell lines.
    Tayyem H, Huq F, Yu JQ, Beale P, Fisher K.
    ChemMedChem; 2008 Jan 15; 3(1):145-51. PubMed ID: 17963210
    [Abstract] [Full Text] [Related]

  • 15. The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model.
    Horowitz NS, Hua J, Gibb RK, Mutch DG, Herzog TJ.
    Gynecol Oncol; 2004 Jul 15; 94(1):67-73. PubMed ID: 15262121
    [Abstract] [Full Text] [Related]

  • 16. The role of glutathione (GSH) in determining sensitivity to platinum drugs in vivo in platinum-sensitive and -resistant murine leukaemia and plasmacytoma and human ovarian carcinoma xenografts.
    Goddard P, Valenti M, Kelland LR.
    Anticancer Res; 1994 Jul 15; 14(3A):1065-70. PubMed ID: 8074451
    [Abstract] [Full Text] [Related]

  • 17. Antitumor activity of cisplatin analogs against malignant ovarian tumor xenografts into nude mice.
    Hamaguchi K, Miyahara K, Nishimura H, Tashiro M, Kishi N, Matsumura T, Yakushiji M, Kato T.
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Nov 15; 40(11):1755-9. PubMed ID: 3069943
    [Abstract] [Full Text] [Related]

  • 18. Apoptosis as a determinant of tumor sensitivity to topotecan in human ovarian tumors: preclinical in vitro/in vivo studies.
    Caserini C, Pratesi G, Tortoreto M, Bedogné B, Carenini N, Supino R, Perego P, Righetti SC, Zunino F.
    Clin Cancer Res; 1997 Jun 15; 3(6):955-61. PubMed ID: 9815771
    [Abstract] [Full Text] [Related]

  • 19. [Effect of a newly developed platinum compound cis-1, 1-cyclobutane dicarboxylato-(2R)-2-methyl-1,4-butane diamine platinum (II), on human ovarian tumors transplanted into nude mice].
    Sawada M, Ozaki M, Taniguchi H, Tateishi R, Mori Y, Mino K.
    Gan To Kagaku Ryoho; 1988 Apr 15; 15(4 Pt 1):637-41. PubMed ID: 3355185
    [Abstract] [Full Text] [Related]

  • 20. [Antitumor activity of a new platinum complex, (R)-(-)-2-aminomethylpyrrolidine (1, 1-cyclobutanedicarboxylato) platinum (II), against cisdiamminedichloroplatinum (II)-resistant murine leukemia cell line].
    Akamatsu K, Endo K, Matsumoto T, Kamisango K, Morikawa K, Koizumi M, Mitsui H, Koizumi K, Matsuno T.
    Gan To Kagaku Ryoho; 1990 Jan 15; 17(1):73-8. PubMed ID: 2404458
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.